my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
22-02-2006: NV Organon, STW Technology Foundation (STW) and Radboud University Nijmegen plan to run a joint project designed to shed light on the process of bone, fat and cartilage formation. Organon and STW will be providing financial support for the study, which will be conducted by Radboud University Nijmegen's Department of Cell Biology and Applied Biology.
The four years research project is in line with the objectives of each of the partners: Organon pursues the development of medicines for bone diseases, STW implements a program focused on tissue engineering innovations, and Radboud University Nijmegen gets an opportunity to unravel the mechanisms triggering stem cells to develop into bone, fat and cartilage tissue.
According to Dr. Ard Cools, Valorization Manager of the STW, the Foundation's financial support is being provided as part of the Dutch Program for Tissue Engineering.
In addition to providing part of the financial support, Organon will also serve as the technology partner.
Watchlist
This is where you can add this news to your personal favourites
Akzo Nobel N.V. has completed the sale of Organon BioSciences N.V. to Schering-Plough Corporation for EUR 11 billion. Confirmation of the completion of the transaction comes after Schering-Plough received all the necessary approvals, including clearance from the U.S. Federal Trade Commissio ... more
Organon, the human healthcare business unit of Akzo Nobel, announced that it has signed an exclusive, worldwide license agreement with Endotis Pharma concerning the development and commercialization of several antithrombotic compounds. Endotis is a specialty pharma company dedicated to the ... more
European expert consortium combines forces to develop a novel pandemic influenza vaccine
A consortium of experts in the field of human virus research and vaccine development have joined forces to develop a novel pandemic influenza vaccine as a potential emergency vaccination. The four-year project has been awarded a grant of EUR3.5 million from the European Union to help fund t ... more
Organon creates, manufactures and markets innovative prescription medicines that improve the health and quality of human life. Through a combination of innovation and business partnerships, Organon seeks to leverage its position as a leading biopharmaceutical company in each of its core the ... more
Developing tiny probes for research and brain-related medical applications – that is the goal of the project NeuroSeeker, launched in February 2013 with a kick-off event in Leuven. The interdisciplinary project pools the expertise of ten partner institutions from Europe and Canada. The Univ ... more
ElexoPharm Receives € 2.1 Million EUROSTARS Grant
A EUROSTARS grant of €2.1 million has been awarded to a transnational consortium consisting of Khondrion BV ( Nijmegen), Radboud University Nijmegen Medical Centre (RUNMC, Nijmegen), Pharmacelsus GmbH (Saarbruecken) and ElexoPharm GmbH (Saarbruecken). This grant, which for the German partne ... more
Greater Accuracy in Gauging Blood Coagulation
Thrombin plays a key role in various pathologies of the haemostatic system. Overexpression of thrombin can result in thrombosis, whereas its underexpression might lead to haemophilia. Therefore, accurate monitoring of thrombin activity is crucial for determining the proper treatment of a gi ... more
Radboud University Nijmegen Medical Centre is a leading academic centre with expertise in medical science and healthcare. Expertise plays an essential part in our organisation and connects research, education and patient care. Our more than 8,500 staff and 3,000 students are committed and a ... more
TET Systems and AMC/STW enter into an assignment agreement
TET Systems Holding (TSH), the Academic Medical Center (AMC), and Technology Foundation STW announced that they have entered into an assignment agreement. Scientists at the AMC have previously developed a novel series of reverse transactivators with improved properties. Under the terms of t ... more
NV Organon, STW Technology Foundation (STW) and Radboud University Nijmegen plan to run a joint project designed to shed light on the process of bone, fat and cartilage formation. Organon and STW will be providing financial support for the study, which will be conducted by Radboud Universit ... more
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
